Number of shares and voting rights as at 28/02/2019
Europlasma declares the number of voting rights and shares comprising its share capital as at 28th February.
Termination of the liquidity contract
The company announces that the liquidity contract entrusted to Kepler Cheuvreux ended on 5 February 2019.
Number of shares and voting rights as at 31/01/2019
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st January.
Group's update
- Declaration of cessation of payments
Cancellation of the General Shareholders' Meeting convened on 25/02/2019
Resumption of trading of Europlasma shares
Europlasma shares trading is suspended pending a press release
Europlasma asked Euronext Paris to suspend the trading of its shares (FR0000044810-ALEUP) from today before the opening of the stock exchange.
Read the press release (in French)
Call to a General Meeting of Shareholders
The shareholders of are informed that they will be convened in a Extraordinary General Meeting on 25 February, 2019.
Read the notice (in French)
Invitation to General Meeting of Shareholders
The Board of Directors of Europlasma met today, as part of a warning procedure from its Statutory Auditors, to convene an Ordinary General Meeting to deliberate on the situation of the Company and the continuity of the operation.
Read the press release (in French)
Number of shares and voting rights as at 31/12/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st December.
Half-year report on liquidity contract as at 31/12/2018
Under the liquidity contract agreed between the company and Kepler Cheuvreux, as at 31 December 2018.
Update on funding prospects
As stated in the previous press release, Europlasma Group and its management are actively pursuing the objective of achieving a capital increase allowing the entry of a reference shareholder and thus ensuring the continuity of its operations.
Read the press release (in French)